Introduction

Insulin resistance: definition
The term insulin resistance can be defined in many ways. It may be defined as inhibition of insulin's action on glucose transport from the extra cellular space (blood and interstitial fluid) into cells of insulin sensitive target tissues (mainly skeletal muscle and fat) 1 . The clinical definition of insulin resistance is the impaired ability of insulin (either endogenous or exogenous) to lower blood glucose and to maintain metabolic homeostasis 4 . In other words, insulin resistance is a pathologic state in which target cells fail to respond to ordinary levels of circulating insulin 5 .
The metabolic syndrome: history 2 Reavan connected insulin resistance with many metabolic disorders such as glucose intolerance, dyslipidemia, hyperuricemia and hypertension. upon observing the more than coincidental existence of obesity, diabetes, hypertension, hyperlipidemia and atherosclerotic coronary disease concomitantly in a single patient6 Reavan suggested that these are caused by a single metabolic disorder, he suggested that the 'insulin resistance syndrome' (IRS) or 'syndrome X' as a cluster of conditions like obesity (especially central obesity), hyperinsulinemia, reduced high density lipoprotein cholesterol level, hypertension and coronary arterial diseases. Further research established this concept with more evidence 6, 3, 7, 8 . Later the term 'the metabolic syndrome' (MS) replaced the term IRS. Mexican-American women (33%) and lowest among white women (21%). It was also high among African-Americans 17 . It is reported to be high among Hispanic adults18, and a study on Arab-Americans shows the prevalence of MS among Arab-Americans using NCEP-ATPIII criteria is 23% 19 . Data from a Brazilian adolescent sample who were first degree relatives of type 2 diabetic subjects shows an overall prevalence of 6% but it was 26.1% in obese adolescents 20 .
The metabolic syndrome: definition
Metabolic syndrome in Europe
The prevalence in France is 10% in male and 7% in female which is 2.5 times less than that of the US 21 . Data of Finish people shows its prevalence is 17% among male and 8% among female Finish people 22 . Ozsahin 23 reported prevalence of MS among Turkish adult population as 39.1% in female and 23.7% in male with overall prevalence of 33.4% and higher frequencies in rural people. Data from Belgium shows its overall prevalence is 20% among Belgians 24 . A study done by Wannmethee25 on a big cohort (n=2722) of UK old people (age 60 yrs and above) free from CVD showed its prevalence of 27% using NCEP-ATPIII 10 criteria.
Metabolic syndrome in Asia
In India the prevalence of metabolic syndrome is 24.9% (age adjusted) 26 . A study on Omani people shows age adjusted prevalence of metabolic syndrome is 21% 27 . Reports from fifth national nutrition survey in Philippines show high prevalence (28%) of MS there 28 . Tan 29 studied prevalence of MS in Singaporean Asian population which includes Chinese, Malay and Indian. They found it more prevalent among Indians (20.4%) then Malay (18.7%) or Chinese (9.4%). Korean national health and nutrition examination survey 1998 shows age-adjusted prevalence of the metabolic syndrome among South Koreans was 14.2% for men and 17.7% for women 30 The prevalence of MS differ from country to country 12,13 , depending on the lifestyle of the population and on genetic influence.
Metabolic syndrome in America
Data from US national survey suggest that the prevalence of insulin resistance syndrome is 24% among US adults aged more than 20 years 14 . Using 2000 census it was estimated that 47 million US residents have the syndrome 13, 15 .
Review of two population based study (San Antonio heart study and Framingham offspring study) shows its age sex adjusted prevalence 24% among US whites, 23% among nonHispanic whites and 31% among MexicanAmericans16. Rates were highest among PMid:3056758 
Conclusion
From our observation we can conclude like Sir George Alberti that 'whichever definition is used and whatever the variation in the numbers due to the different criteria, when looking at prevalence data for the metabolic syndrome in different countries and across various ethnic groups, one fact is clear. Universally, the metabolic syndrome is a huge problem and is one that is growing at an alarming rate'. Global awarness and preparation is needed to combat the future crisis. 
